# Metabolic Effects of Antipsychotics in Children

> **NCT00205699** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 144 (actual)

## Conditions studied

- Aggression
- Attention Deficit-Hyperactivity
- Oppositional Defiant Disorder
- Pervasive Development Disorders
- Bipolar Disorder

## Interventions

- **DRUG:** risperidone
- **DRUG:** olanzapine
- **DRUG:** aripiprazole

## Key facts

- **NCT ID:** NCT00205699
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-07
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2018-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00205699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00205699, "Metabolic Effects of Antipsychotics in Children". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00205699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*